Ekso Bionics Holdings Inc. has approved new equity award grants and severance agreements for executives Scott Davis, Jerome Wong, and Jason Jones. The executives received restricted stock units (RSUs) covering 80,000, 19,500, and 15,000 shares respectively, all of which are fully vested as of the grant date. Additionally, they were granted phantom performance-based RSUs (Phantom PSUs) for 185,000, 40,000, and 32,000 notional shares, which will vest if both a company change in control and a stock price of at least $7.50 are achieved within five years. The new severance agreements provide for continued base salary payments for six months (nine months for Davis) if employment is terminated by the company without cause outside of a change in control period. If termination occurs by the company without cause or by executive resignation for good reason within a change in control period, the executives will receive a lump sum equal to nine months' base salary (18 months for Davis) and medical coverage for the same period.